Mutation-specific targeted therapies
Search documents
Incyte Corporation (INCY) Presents at Jefferies London Healthcare Conference 2025 Transcript
Seeking Alphaยท 2025-11-18 18:48
Question-and-Answer SessionSo Bill, let's start from the big picture. You've been in the CEO role for 6 months now. Tell us how you've enjoyed your time since joining and how your initial vision is coming to life?William MeuryCEO, President & Director Good afternoon, everyone. It's good to see you. It's been busy. Great company. Great culture, I think, strong organizational DNA and most importantly, which is one of the reasons I joined, just a lot of substrate in terms of meaningful product flow over the ne ...
Incyte (NasdaqGS:INCY) 2025 Conference Transcript
2025-11-18 12:02
Incyte (NasdaqGS:INCY) 2025 Conference November 18, 2025 06:00 AM ET Company ParticipantsPablo Cagnoni - Head of R and DBill Meury - CEOConference Call ParticipantsClara Dunn - Biotech AnalystClara DunnAll right, good morning. Thank you, everyone, for joining Jefferies Healthcare Conference in London. My name is Clara Dunn, one of the biotech analysts here at Jefferies. Sitting next to me, we have the Chief Executive Officer from Incyte, Bill Meury, and the Head of R&D, Pablo Cagnoni. Thank you very much fo ...